Press Releases

The Assistance Fund Opens New Program for Hepatocellular Carcinoma

FOR IMMEDIATE RELEASE

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Hepatocellular Carcinoma

ORLANDO, Fla., January 23, 2023 —The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new copay assistance program for people living with hepatocellular carcinoma. The program is designed to help eligible individuals pay for their out-of-pocket medical expenses related to hepatocellular carcinoma, such as copays, deductibles, and coinsurance.

People diagnosed with hepatocellular carcinoma, the most common form of liver cancer, often experience abdominal discomfort, weight and appetite loss, and jaundice. Depending on the situation, some patients require chemotherapy, radiation, or targeted therapies.[1] Nearly 35,000 Americans are diagnosed with liver cancer every year.[2]

“Receiving a cancer diagnosis can be tremendously overwhelming for both patients and their families,” said Gerald Lauria, Senior Vice President of Business Development and Strategy for The Assistance Fund. “I’m grateful to our generous donors for enabling us to open our new Hepatocellular Carcinoma Copay Assistance Program, which will alleviate patients’ financial burden of accessing treatment.”

To learn more or determine eligibility for financial support, visit tafcares.org or call (855) 228-9972 to speak with a Patient Advocate.

A list of all the disease programs available from The Assistance Fund can be found on the website tafcares.org.

About The Assistance Fund

The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages more than 80 disease programs, each of which covers all FDA-approved medications that treat a specific disease named in the disease program. Since its founding in 2009, TAF has helped more than 160,000 children and adults access the treatment they need to stay healthy or manage a life-threatening, chronic, or rare disease. To learn more about The Assistance Fund, or for information on how to donate, please visit tafcares.org.

Media Contact

Margaret Figley

Senior Director of Communications

margaret.figley@tafcares.org

[1] Mayo Clinic, “Hepatocellular Carcinoma,” https://www.mayoclinic.org/diseases-conditions/hepatocellular-carcinoma/cdc-20354552#, accessed January 2023.

[2] Centers for Disease Control and Prevention, “Liver Cancer,” https://www.cdc.gov/cancer/liver/index.htm, accessed January 2023.

Share This
Categories: Press Releases